Position in BJDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$51,753
+$44,913 QoQ
Shares Held
28,127
+997.0% QoQ
Ownership
0.630%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BJDX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $16,628,532,197 across 127 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
39,219,337 | $3,558,762,638 | |
| 2 | SYK |
Stryker Corp
|
7,819,802 | $2,461,986,461 | |
| 3 | MDT |
Medtronic plc
|
30,192,015 | $2,361,921,333 | |
| 4 | BSX |
Boston Scientific Corp
|
33,440,102 | $1,427,223,552 | |
| 5 | EW |
Edwards Lifesciences Corp
|
15,437,251 | $1,396,453,724 | |
| 6 | DXCM |
Dexcom Inc
|
12,426,515 | $836,925,784 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
12,871,800 | $823,923,917 | |
| 8 | STE |
STERIS plc
|
2,615,842 | $550,817,849 |
All Filings in BJDX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $51,753 | 28,127 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,840 | 10,256 | Shares | Defined | 2026-02-09 | |
| 2024-09-30 | $2,563 | 20,185 | Shares | Defined | 2024-11-12 | |
| 2023-06-30 | $7,663 | 29,139 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,917 | 29,139 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10 | 30,220 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,571 | 30,220 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,165 | 12,420 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||